Belong.Life, a developer of social networks for managing and navigating treatments and the creator of the world’s largest social network for cancer patients, announced the launch of its new free and anonymous AI-powered social-networking and navigation platform for multiple sclerosis patients, caregivers and health-care professionals: BelongMS.

The app, which can be downloaded for Android and iOS, follows the success of Belong’s global social-networking and navigation app for cancer management, the largest platform of its kind.

BelongMS utilizes proprietary machine-learning algorithms and domain expertise to provide hyper-personalized information to support patients, including support groups and direct access to medical professionals such as neurologists, radiologists, urologists and others who can answer patient questions.

The app also provides tools like a medical-binder manager to store and organize medical records in one place with the option to share them securely and privately with family members or physicians.

A clinical matching trial feature is also available, utilizing Natural Language Processing (NLP) algorithms to analyze all available trials around the globe to match patients within two weeks on average.

“We are leveraging our market-proven experience in patient engagement, backed by disruptive technology, to provide effective support for patients across the health-care continuum,” said Belong.Life co-founder and CEO Eliran Malki. “People who receive challenging diagnoses need to make critical decisions and have access to the relevant data and support they need.”

BelongMS was initially launched in Israel, with one in four local MS patients now engaging with the app, which will now be available globally.

Support Jewish Journalism
with 2020 Vision

One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.

JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.

During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.

Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.